Skip to content

AVANST

Active
Private limited companyfounded 2023active for 2 yearsBosstraat 13, 3060 Bertem, BelgiumKBO/BCE: BE 1003.024.441
Summary

AVANST has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,348 and a net result of €48,998. Equity has been growing by about 93% per year since 2023. Its solvency ranks better than 69% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 05-12-2023 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.353.214.060 3060 Bertem, since 05-12-2023
Financial year end
31 December
Peppol
Reachable since 09-12-2025

Board and ownership

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€61,874
▲ 13.5%
Turnover
≈ €140,000
estimated
Profit
€48,998
▲ 14.9%
Equity
€98,348
▲ 99.3%
Total assets
€124,678
▲ 104%
Filed on 13-05-2026, 79 days before the deadline
Score breakdownraises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.74, cash €92,447Equity €98,348 (78.9% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 83% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 78.9% of total assets
Liquidity 93-1
short-term debt 21.1% · cash 74.1%
Profitability 100=
return on assets 39.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 01-2025: 0.1% 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 4.74 (5.24 in 2024), above the usual 1.5. Short-term debt is 21.1% and cash 74.1% of total assets. 21.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 79% on liquidity, 80% on profitability and 90% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.74, cash €92,447
NBB · annual accounts
lowers risk · Equity €98,348 (78.9% of total assets)
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
79 days early
2024
35 days early
2023
30 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 48 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (3 of the last 3 accounts filed within 44 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Financials

Financials · financial year 2025, micro format

Annual accounts 2025 filed on 13-05-2026 PDF all 3 filings

Turnover
≈ €140,000
Estimated: probably between €110,000 and €180,000
Total assets
€124,678▲ 104%
2024 · €60,983
Net result
€48,998▲ 14.9%
2024 · €42,653
Working capital
€98,348▲ 99.3%
2024 · €49,351
Trend over the years

2023 to 2025, 3 financial years

The operating result for 2025 is 14% higher than in 2024 and the highest since 2023. It is the second rise in a row.

Operating result€61,662 2025 Net result€48,998 2025

Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.

Use the arrow keys on the chart for the figures per year.

The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€8,246-€54,236▲ 558%€61,662▲ 13.7%
Net result€6,597below the sector's middle half-€42,653within the sector's middle half▲ 547%€48,998within the sector's middle half▲ 14.9%
Equity€6,697below the sector's middle half-€49,351within the sector's middle half▲ 637%€98,348within the sector's middle half▲ 99.3%
Total assets€9,944below the sector's middle half-€60,983below the sector's middle half▲ 513%€124,678within the sector's middle half▲ 104%
Debt€3,246-€11,632▲ 258%€26,330▲ 126%
Working capital€7,241below the sector's middle half-€49,351within the sector's middle half▲ 582%€98,348within the sector's middle half▲ 99.3%
Solvency67.4%within the sector's middle half-80.9%within the sector's middle half▲ 13.6pp78.9%within the sector's middle half▼ 2.0pp
Current ratio3.68within the sector's middle half-5.24within the sector's middle half▲ 1.564.74within the sector's middle half▼ 0.51
Return on assets (ROA)66.3%above the sector's middle half-69.9%above the sector's middle half▲ 3.6pp39.3%within the sector's middle half▼ 30.6pp
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €124,678
Equity €98,348 ▲ 99.3%
Debt €26,330 ▲ 126%
Debt's share of the balance-sheet total rises from 19.1% to 21.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.27▲
2024 · 0.24
ROE
49.8%▼
2024 · 86.4%
Debt ≤ 1 year
€26,330▲
2024 · €11,632
Income taxes
€13,213▲
2024 · €11,617
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Comparable companies

These companies have the same main activity as AVANST: general medical practice (NACE 86210). They are comparable in size and age: total assets between €108,000 and €135,000, founded between 2023 and 2024.

CompanyFoundedTotal assetsEquityGross marginTurnoverNet resultFinancial year
AVANST Bertem2023€124,678€98,348€61,874-€48,9982025
Dr. Katharina Lobisch Kortenberg2023€135,083€100,788€58,902-€41,7222025
Hatico Oud-Heverlee2024€120,781€73,283€66,104-€40,6072025
Dokter De Ridder, huisarts Herent2024€119,081€69,049€68,178€140,979€46,2922025
Dokter Eric Vleeshouwers Leuven2023€108,480€104,756€65,813-€50,6782025
Dokter Charista Santoso BV Haacht2023€134,741€99,139€55,079-€42,0712025
Dr. Annelien Tits Waasmunster2024€118,790€98,986€60,930-€47,3332025

They were chosen from the 6,466 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity

Companies with the same profile, two years later

Historical observation

In July 2024, 39,278 companies had the same profile as AVANST has now. Two years later, 1.8% had gone bankrupt and 95.9% were still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.9% was still going

The bankruptcy probability of AVANST itself is lower: < 0.1% within 12 months. It rests on far more data about AVANST than the profile alone.

Test of the method

The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for AVANST. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 31 lines

Source: Annual accounts 2025 (PDF), filed on 13-05-2026.

Balance sheet Code20242025
Assets
Total assets20/58€60,983€124,678▲
Current assets29/58€60,983€124,678▲
Amounts receivable within one year40/41€3,631€18,217▲
Other amounts receivable41€3,631€18,217▲
Cash at bank and in hand54/58€51,552€92,447▲
Deferred charges and accrued income490/1€5,800€14,014▲
Equity and liabilities
Total equity and liabilities10/49€60,983€124,678▲
Equity10/15€49,351€98,348▲
Contributions10/11€100€100=
Reserves13€49,251€98,248▲
Distributable reserves133€49,251€98,248▲
Amounts payable17/49€11,632€26,330▲
Amounts payable within one year42/48€11,632€26,330▲
Trade debts44€16-
Suppliers440/4€16-
Taxes, remuneration and social security45€11,617€26,330▲
Taxes450/3€11,617€26,330▲
Income statement Code20242025
Other operating charges640/8€291€212▼
Gross operating margin9900€54,527€61,874▲
Operating profit (loss)9901€54,236€61,662▲
Financial income75/76B€78€594▲
Recurring financial income75€78€594▲
Financial charges65/66B€44€45▲
Recurring financial charges65€44€45▲
Profit (loss) for the period before taxes9903€54,270€62,210▲
Income taxes67/77€11,617€13,213▲
Profit (loss) for the period9904€42,653€48,998▲
Profit (loss) for the period to be appropriated9905€42,653€48,998▲
Appropriation of the result
Profit (loss) to be appropriated9906€42,653€48,998▲
Transfer to equity691/2€42,653€48,998▲
To other reserves6921€42,653€48,998▲

The notes to these accounts have 1 item. You find them in the filed accounts (PDF).

Line202320242025Change
Other operating charges640/8€150€291€212▼ 27.2%
Gross operating margin9900€8,396€54,527€61,874▲ 13.5%
Operating profit (loss)9901€8,246€54,236€61,662▲ 13.7%
Financial income75/76B-€78€594▲ 660%
Recurring financial income75-€78€594▲ 660%
Financial charges65/66B-€44€45▲ 3.4%
Recurring financial charges65-€44€45▲ 3.4%
Profit (loss) for the period before taxes9903€8,246€54,270€62,210▲ 14.6%
Income taxes67/77€1,649€11,617€13,213▲ 13.7%
Profit (loss) for the period9904€6,597€42,653€48,998▲ 14.9%
Profit (loss) for the period to be appropriated9905€6,597€42,653€48,998▲ 14.9%
Line202320242025Change
Assets
Total assets20/58€9,944€60,983€124,678▲ 104%
Current assets29/58€9,944€60,983€124,678▲ 104%
Amounts receivable within one year40/41-€3,631€18,217▲ 402%
Other amounts receivable41-€3,631€18,217▲ 402%
Cash at bank and in hand54/58€325€51,552€92,447▲ 79.3%
Deferred charges and accrued income490/1€9,619€5,800€14,014▲ 142%
Equity and liabilities
Total equity and liabilities10/49€9,944€60,983€124,678▲ 104%
Equity10/15€6,697€49,351€98,348▲ 99.3%
Contributions10/11€100€100€100=
Reserves13€6,597€49,251€98,248▲ 99.5%
Distributable reserves133€6,597€49,251€98,248▲ 99.5%
Amounts payable17/49€3,246€11,632€26,330▲ 126%
Amounts payable within one year42/48€2,702€11,632€26,330▲ 126%
Trade debts44-€16--
Suppliers440/4-€16--
Taxes, remuneration and social security45€1,649€11,617€26,330▲ 127%
Taxes450/3€1,649€11,617€26,330▲ 127%
Other amounts payable47/48€1,053---
Accrued charges and deferred income492/3€544---
Line202320242025Change
Profit (loss) for the period9904€6,597€42,653€48,998▲ 14.9%
Operating cash flow (approximation)€6,597€42,653€48,998▲ 14.9%
Change in cash-€51,228€40,895▼ 20.2%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference Document
31-12-2025 micro format 13-05-2026 2026-00110016 PDF
31-12-2024 micro format 26-06-2025 2025-00179778 PDF
31-12-2023 micro format 01-07-2024 2024-00187254 PDF

Board & ownership

Directors

Directors
1 director, no change since 2023
VANDER ELST Amadeo Kris Gerda
Director (not named in the articles) · appointed in the act of 07-12-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 13-05-2026
Current

Owners and capital

Shareholders

At incorporation act of 07-12-2023 ↗

Capital transactions

Capital over time
  1. 07-12-2023 Incorporation · 100 shares

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
“1, alle handelingen behalve voorbehouden aan algemene vergadering door wet of statuten”
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Articles of association, deed of 07-12-2023 (in Dutch)

Network & group

AVANST shares no director with another company.

Connections & network

1 current director
Depth

The network starts from the directors of AVANST. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
13-05
NBB filing Annual accounts 2025 filedPDF
micro format · 79 days before the deadline
2025
31-12
Financial Highest result from 2023 to 2025net €48,998 ▲14.9%
The operating result of €61,662 and the net result of €48,998 are both a record.
26-06
NBB filing Annual accounts 2024 filedPDF
micro format · 35 days before the deadline
2024
01-07
NBB filing Annual accounts 2023 filedPDF
micro format · 30 days before the deadline
2023
07-12
Gazette deed Incorporation
Appointment: VANDER ELST Amadeo Kris Gerda (director) · Founder · Founding capital4 points ▸
  • Incorporation, “AVANST” (deed in Dutch)
  • Founder, VANDER ELST Amadeo Kris Gerda
  • Founding capital
  • Director appointment, VANDER ELST Amadeo Kris Gerda (director (not named in the articles))

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

AVANST was incorporated on 5 December 2023 as a private limited company by one natural person.12 VANDER ELST Amadeo Kris Gerda is director of the company, appointed in the act of 07-12-2023.2 Total assets rose from €9,944 in 2023 to €124,678 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 07-12-2023
  3. 3National Bank, annual accounts 2023 and 2025

Company details

Register details

Identity

KBO record
Name AVANST in Dutch
Enterprise number 1003.024.441
Legal form Private limited company
Status Active, normale toestand
Founded 05-12-2023
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 07-12-2023 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest, 3060 Bertem,Bosstraat 13”
deed of 07-12-2023 (in Dutch)

Registered office and establishments

Registered office Bosstraat 13, 3060 Bertem, Belgium
Establishment unit Bosstraat 13, 3060 Bertem since 05-12-2023 · unit number 2.353.214.060

Activities

NACEBEL 2025
86210 General medical practice main activity
85599 Other education
Codes under NACEBEL 2008
86210 General medical practice main activity
85599 Other education

Invoicing and payment

VAT number BE 1003.024.441
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:1003024441
Other Peppol ID 9925:BE1003024441
Registered 09-12-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 1 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of May at 20:00
deed of 07-12-2023 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map

Buildings and parcels at the address

Ground area
979 m²
Building footprint
80 m²
Cadastral parcel Region Area Buildings Height / floors
24009B0341/00Z017 Flanders 979 m² 1 · 80 m² -